SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending due to significant community anticipation surrounding its pivotal role in next-generation AI data centers, particularly with its advanced power solutions crucial for high-density computing infrastructure. The company's upcoming participation in a key industry conference is fueling discussions, as many investors speculate on potential news catalysts and the high short interest driving a prospective squeeze.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu Crypto is experiencing a surge in conversation fueled by its exceptionally active and dedicated community, which is relentlessly building a "permissionless brand" with numerous real-world products like Kendu Spice and Kendu Energy. This collective effort, marked by strong IRL initiatives and a long-term vision, sets KENDU apart, leading to a prevalent bullish sentiment across the crypto space.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending amid intense debate, as investors grapple with its persistent stock decline despite new strategic AI partnerships and potential tailwinds from discussions around credit card interest rate caps. While many criticize management and predict further drops given recent analyst downgrades, a significant portion of the community views PYPL as profoundly undervalued, actively accumulating shares and anticipating a strong rebound.

Ribbon Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 17, 2024 and is headquartered in Tokyo, Japan.

Ribbon Acquisition Corp. - Ordinary Shares - Class A

Ribbon Acquisition Corp. is attracting significant attention as a 'fresh SPAC,' with community discussions highlighting a recent vote and anticipation of a catalyst. Many are observing its small float and perceived low risk near its NAV, drawing comparisons to other SPACs that have seen rapid movements.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is generating significant buzz following promising Phase 1 clinical data for CTX310, demonstrating deep and durable lipid reductions without serious adverse events. This breakthrough, published in The New England Journal of Medicine, validates the company's in vivo gene-editing platform and excites the community about its potential as a "one-and-done" treatment for severe lipid disorders. Investors anticipate substantial market recognition for this development, alongside ongoing pipeline progress in a field gaining new regulatory support.

Monero

Monero (XMR) is trending strongly as its community champions it as the 'king of privacy' and the 'real Bitcoin' amid growing global discourse on digital anonymity. Despite discussions around regulatory scrutiny of privacy tokens, XMR demonstrates significant momentum, with users emphasizing its superior decentralization and robust technology over alternatives.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is generating significant conversation driven by intense speculation around a potential acquisition, especially as the J.P. Morgan conference fuels rumors of a strategic buyer like Novartis eyeing its cardiovascular assets. The community is also closely monitoring ongoing legal proceedings concerning patent validity, with recent delays sparking varied interpretations, while strong preliminary financial results showing positive cash flow are contributing to a cautious optimism about the company's future value.

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Travere Therapeutics Inc

Travere Therapeutics is experiencing significant volatility and a pre-decision sell-off as the market reacts to the FDA's recent request for additional clarification on the clinical benefit of FILSPARI for the FSGS indication. While some investors view this information request as a strong signal for a potential Complete Response Letter or delay, leading to sharp declines, others are actively buying the dip, viewing the steep decline as an overreaction given the drug's strong efficacy and high unmet need. The community is actively debating whether this is a common regulatory step or a fundamental setback for a therapy poised to become the first approved treatment for FSGS, a rare kidney disorder.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is actively discussed following its acquisition of a mobile analysis facility that will dramatically expedite rare-earth assay results from its key Greenland project. This development aligns with intense geopolitical focus on Greenland's critical mineral potential, as the community eagerly anticipates outcomes from high-level U.S.-Danish-Greenlandic meetings and speculates on CRML's strategic importance in securing Western rare-earth supply chains.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific is currently trending following a recent upgrade to "Buy" from BTIG, with analysts citing improved prospects after the CoreWeave merger rejection and strong demand for high-performance computing power. However, community sentiment is divided, with some investors bullish on the company's AI infrastructure pivot and increasing institutional ownership, while others express concerns over CoreWeave's CEO attributing data center delays to an unnamed third-party provider. This creates a contentious discussion between long-term growth potential and immediate execution challenges.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulmonx Corporation (NASDAQ:LUNG) Short Interest Update

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) was the recipient of a large increase in short interest during the month of December. As of December 15th, there was short interest totaling...

Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Rating of "Hold" by Brokerages

Shares of Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) have earned a consensus rating of "Hold" from the ten ratings firms that are currently covering the stock, Marketbeat.com reports. One...

Pulmonx (NASDAQ:LUNG) Trading Up 2.5% - Here's What Happened

Pulmonx (NASDAQ:LUNG) Shares Up 2.5% - Should You Buy...

Pulmonx (NASDAQ:LUNG) CEO Glendon French III Sells 8,805 Shares

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) CEO Glendon French III sold 8,805 shares of Pulmonx stock in a transaction dated Monday, December 1st. The shares were sold at an average price of...

Insider Selling: Pulmonx (NASDAQ:LUNG) General Counsel Sells 10,278 Shares of Stock

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) General Counsel David Aaron Lehman sold 10,278 shares of the firm's stock in a transaction on Monday, December 1st. The shares were sold at an...

Insider Selling: Pulmonx (NASDAQ:LUNG) CEO Sells 8,805 Shares of Stock

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) CEO Glendon French III sold 8,805 shares of the firm's stock in a transaction dated Monday, December 1st. The shares were sold at an average price...

Pulmonx Corporation $LUNG Shares Sold by Primecap Management Co. CA

Primecap Management Co. CA trimmed its position in shares of Pulmonx Corporation (NASDAQ:LUNG - Free Report) by 4.6% in the second quarter, according to its most recent filing with the Securities and...

Pulmonx (NASDAQ:LUNG) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded Pulmonx from a "sell" rating to a "hold" rating in a report on Sunday...

Pulmonx (NASDAQ:LUNG) Receives "Buy" Rating from D. Boral Capital

D. Boral Capital reiterated a "buy" rating and set a $14.00 price target on shares of Pulmonx in a research note on Thursday...

Pulmonx (NASDAQ:LUNG) Announces Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Pulmonx (NASDAQ:LUNG - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.40) by $0.06. The...

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

Pulmonx Corp

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$1.99
Prev Close	$2.04
Open	$2.04
Dividend Yield	0.00%
50-Day Moving Average	$2.01
Beta	1.17
Avg. Volume	937,801.32
PE Ratio	-1.41

52-Week High	$9.37
52-Week Low	$1.31
Market Capitalization	$84.14M
EPS (Annual)	-$1.44
Price to Book	1.37
Revenue Per Employee	$287,934.71
Enterprise Value/EBITDA	N/A

LUNG
Pulmonx Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LUNG News

LUNGPulmonx Corp